{"product_id":"2022-2027-uruguay-transfusion-diagnostics-market-opportunities-2022-shares-and-five-year-forecasts-immunohematology-and-infectious-disease-screening-analyzers-and-reagents-competitive-shares-and-growth-strategies-volume-and-sales-segment-forecasts-b","title":"2022-2027 Uruguay Transfusion Diagnostics Market Opportunities, 2022 Shares and Five-Year Forecasts - Immunohematology and Infectious Disease Screening Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts b","description":"\u003cp\u003e2022-2027 Uruguay Transfusion Diagnostics Market Opportunities, 2022 Shares and Five-Year Forecasts - Immunohematology and Infectious Disease Screening Analyzers and Reagents - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers\u003c\/p\u003e\n\n\u003cp\u003eThis new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.\u003c\/p\u003e\n\n\u003cp\u003eThe report provides test volume and sales forecasts; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.\u003c\/p\u003e\n\n\u003cp\u003eBlood Typing and Grouping Tests\u003c\/p\u003e  \n\n\u003cp\u003eABO, Antibody Panels, Antibody Screening\/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du)\u003c\/p\u003e\n\n\u003cp\u003eInfectious Disease Screening Tests\u003c\/p\u003e\n\n\u003cp\u003eAIDS (HIV NAT, HIV-1\/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, ALT\/SGPT), HTLV-I\/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Assessments\u003c\/p\u003e \n\n\u003cp\u003e- Strategic assessments of major suppliers and emerging market entrants, including their sales, M\u0026amp;A, product portfolios, marketing tactics, and new products in R\u0026amp;D.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation Analysis\u003c\/p\u003e \n\n\u003cp\u003e- Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT.\u003c\/p\u003e\n\n\u003cp\u003eCurrent and Emerging Products\u003c\/p\u003e\n\n\u003cp\u003e- Analysis of current and emerging blood typing, grouping and infectious disease NAT screening assays.\u003c\/p\u003e\n\n\u003cp\u003e- Review of automated and semi-automated molecular and immunohematology analyzers.\u003c\/p\u003e\n\n\u003cp\u003eTechnology Review\u003c\/p\u003e\n\n\u003cp\u003e- Assessment of current and emerging technologies, and their potential applications for the blood banking market.\u003c\/p\u003e\n\n\u003cp\u003e- Comprehensive lists of companies developing or marketing new technologies and products, by test.\u003c\/p\u003e\n\n\u003cp\u003eBlood Group Genotyping\u003c\/p\u003e  \n\n\u003cp\u003ePCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing\u003c\/p\u003e \n\n\u003cp\u003eMicroarrays\u003c\/p\u003e  \n\n\u003cp\u003eBeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing\u003c\/p\u003e\n\n\u003cp\u003eStrategic Recommendations\u003c\/p\u003e\n\n\u003cp\u003e- New product development opportunities for blood typing, grouping and infectious disease NAT assays and instrumentation with significant market appeal.\u003c\/p\u003e\n\n\u003cp\u003e- Alternative market penetration strategies.\u003c\/p\u003e\n\n\u003cp\u003e- Potential market entry barriers and risks.\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"November, 2022 \/ - \/ MCW16233846","offer_id":47650832482610,"sku":null,"price":1140.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/2022-2027-uruguay-transfusion-diagnostics-market-opportunities-2022-shares-and-five-year-forecasts-immunohematology-and-infectious-disease-screening-analyzers-and-reagents-competitive-shares-and-growth-strategies-volume-and-sales-segment-forecasts-b","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}